new
coronaviru
sarscov
aetiolog
agent
sever
acut
respiratori
syndrom
sar
critic
role
play
serolog
assay
sar
diagnosi
inhous
elisa
base
sarscov
recombin
antigen
develop
sarscov
nucleocapsid
protein
n
three
n
fragment
intravir
domain
membran
protein
clone
express
escherichia
coli
histidinetag
protein
six
refer
sera
sar
patient
use
detect
virusspecif
igg
elisa
use
recombin
protein
coat
antigen
hightitr
posit
reaction
detect
sar
posit
sera
specif
assay
appear
high
posit
reaction
detect
sera
healthi
subject
patient
nonsar
lowtract
respiratori
infect
specif
hyperimmun
sera
sarscov
recombin
protein
n
also
gener
mice
rabbit
specif
sera
confirm
immunocytochem
assay
biochip
sarscov
infect
uninfect
cell
outbreak
sever
acut
respiratori
syndrom
sar
swept
world
earli
spread
china
sever
countri
differ
contin
caus
case
roughli
mortal
rate
donnelli
et
al
new
coronaviru
sarscov
etiolog
agent
syndrom
accordingli
molecular
virolog
serolog
test
develop
identif
poon
et
al
although
retrospect
natur
serolog
test
utmost
import
either
confirm
rule
infect
viru
seropreval
studi
context
viral
nucleocapsid
protein
n
membran
protein
recogn
use
antigen
monitor
antibodi
respons
coronaviru
infect
ndifuna
et
al
chen
et
al
elia
et
al
n
antigen
also
use
detect
antisarscov
antibodi
despit
intens
research
area
ndifuna
et
al
che
et
al
shi
et
al
shi
et
al
leung
et
al
liu
et
al
woo
et
al
wu
et
al
need
improv
sar
serolog
wide
recogn
poon
et
al
recombin
protein
potenti
inexpens
safe
easi
standard
serolog
reagent
also
repres
safest
way
prepar
viral
antigen
sinc
obtain
without
propag
live
viru
fact
consider
import
view
recogn
capac
sarscov
infect
laboratori
worker
thu
sar
diagnosi
seropreval
studi
inhous
elisa
develop
laboratori
act
nation
refer
center
infecti
emerg
assay
base
use
sarscov
recombin
n
structur
protein
coat
antigen
purifi
n
protein
also
use
gener
specif
polyclon
antibodi
detect
sarscov
antigen
clinic
specimen
n
fulllength
gene
gener
rtpcr
technolog
ml
sampl
contain
heat
gammairradi
cell
cultur
supernat
vero
cell
infect
sarscov
isol
frankfurt
thiel
et
al
oligonucleotid
use
list
tabl
bamhi
psti
sequenc
ad
end
forward
fw
revers
rv
primer
respect
bamhipsti
restrict
cdna
clone
qiagen
introduc
transform
escherichia
coli
cell
obtain
construct
pn
pm
respect
protein
express
ntermin
mrg
h
tag
protein
amino
acid
aa
centraldomain
aa
coohterminu
aa
n
protein
cytoplasmicdomain
aa
protein
also
clone
obtain
construct
respect
number
refer
n
embl
sequenc
recombin
protein
purifi
affin
chromatographi
ninta
resin
use
denatur
protocol
accord
manufactur
instruct
qiaexpressionist
protein
solubil
urea
pb
except
protein
n
solubil
guanidin
hydrochlorid
pb
protein
puriti
quantiti
analyz
sdspage
follow
stain
coomassi
blue
standard
method
lowri
respect
protein
ident
confirm
western
blot
use
anti
polyhistidin
antibodi
sigmaaldrich
st
loui
mo
six
sarscovposit
sera
collect
robert
koch
institut
berlin
itali
act
within
european
network
diagnost
import
viral
diseas
envid
kindli
obtain
prof
peiri
univers
hong
kong
china
dr
zambon
health
protect
agenc
london
sera
patient
confirm
sar
accord
criteria
document
titr
immunofluoresc
elisa
neutral
assay
use
qualiti
control
differ
serolog
assay
perform
differ
european
laboratori
act
nation
refer
center
sar
diagnosi
sera
healthi
donor
patient
affect
viral
nonsar
bacteri
acut
respiratori
syndrom
serv
control
sarscov
recombin
protein
mgwell
denatur
form
adsorb
carbon
buffer
ph
microtit
plate
overnight
incub
twofold
dilut
serum
start
dilut
nbase
elisa
respect
incub
primari
secondari
antibodi
perform
hr
antigenantibodi
complex
detect
goat
antihuman
ig
igm
igg
iga
h
l
peroxidaseconjug
southern
biotechnolog
associ
inc
birmingham
al
use
tmb
vector
laboratori
inc
burlingham
ca
substrat
optic
densiti
read
nm
hyperimmun
mous
sera
produc
intraperiton
immun
mice
week
old
previous
describ
di
bonito
et
al
use
mg
purifi
protein
per
mous
purifi
protein
mg
per
anim
also
inocul
intraderm
four
time
interv
albino
new
zealand
rabbit
prime
immun
made
antigen
emulsifi
freund
complet
adjuv
mlrabbit
first
second
booster
contain
antigen
freund
incomplet
adjuv
mlrabbit
final
booster
consist
blot
use
correspond
recombin
protein
antigen
slide
contain
biochip
sarscov
infect
uninfect
cell
euroimmun
italia
padova
itali
treat
fetal
calf
serum
pb
min
remov
aspecif
reaction
rabbit
mous
antisera
serial
dilut
respect
pb
nonfat
dri
milk
incub
cell
sampl
hr
room
temperatur
antigenantibodi
complex
reveal
detect
system
use
label
polym
method
dako
envis
tm
system
horseradish
peroxidas
carpinteria
ca
sampl
observ
light
microscop
leitz
germani
total
magnif
indic
legend
figur
n
structur
sarscov
protein
chosen
develop
elisa
test
detect
specif
antivir
antibodi
n
fulllength
gene
amplifi
heat
gammairradi
cell
cultur
supernat
vero
cell
infect
sarscov
isol
frankfurt
amplifi
cdna
clone
express
vector
qiagen
obtain
pn
pm
construct
respect
cterminu
extramembran
tail
protein
amino
acid
clone
sequenc
fig
panel
deduc
amino
acid
sequenc
insert
compar
n
sequenc
sarscov
frankfurt
isol
reveal
amino
acid
ident
thu
assur
clone
method
insert
spuriou
amino
acid
variat
whole
protein
could
gener
probabl
toxic
e
coli
recombin
fragment
well
full
length
n
protein
success
express
e
coli
fig
panel
b
recombin
protein
purifi
use
coat
antigen
elisa
set
analyz
sarsposit
human
sera
twenti
human
sera
healthi
blood
donor
sarsneg
sera
patient
affect
acut
respiratori
syndrom
viral
nonsar
bacteri
etiolog
use
neg
control
sera
sar
patient
show
strong
posit
reaction
n
antigen
contrast
posit
reaction
observ
serum
nonsar
subject
dilut
cutoff
consid
suggest
high
specif
test
figur
particularli
show
titrat
curv
sar
serum
sampl
obtain
elisa
use
panel
whole
n
antigen
panel
b
also
show
antibodi
titr
gener
lower
antin
titr
nonetheless
respons
show
particularli
low
intersubject
variabl
compar
antin
respons
mean
od
read
valu
six
sar
sera
test
either
n
antigen
dilut
respect
shown
figur
panel
c
togeth
valu
nonsar
subject
od
hightitr
elisa
result
confirm
western
blot
show
expect
immunoreact
viral
protein
band
data
shown
three
n
fragment
also
express
describ
method
fig
panel
deduc
protein
sequenc
n
fragment
compar
n
sequenc
sarscov
frankfurt
isol
reveal
amino
acid
ident
except
construct
tyr
posit
replac
ala
three
n
fragment
purifi
use
coat
antigen
elisa
analyz
six
sarscov
refer
sera
fig
case
clearcut
posit
reaction
six
sarsposit
human
sera
detect
particular
central
n
portion
panel
b
demonstr
high
level
posit
reaction
od
averag
valu
dilut
ae
respect
neg
sera
ae
protein
gener
lower
posit
reaction
reach
dilut
od
averag
valu
ae
neg
sera
mean
valu
ae
ae
neg
sera
mean
valu
ae
respect
specif
elisa
assay
fig
panel
e
fig
panel
would
appear
rather
high
posit
reaction
observ
nand
elisa
dilut
two
sarsneg
sera
show
weak
posit
reaction
antigen
dilut
read
howev
twofold
lower
mean
sarsposit
sera
valu
posit
reaction
nonsar
sera
howev
observ
dilut
result
describ
show
high
immunogen
n
protein
sar
patient
prompt
us
produc
polyclon
antibodi
recombin
protein
use
detect
viral
antigen
thu
five
sarscov
recombin
protein
purifi
inocul
either
rabbit
mice
order
gener
specif
hyperimmun
sera
viral
protein
show
high
immunogen
anim
speci
induc
specif
antibodi
reactiv
elisa
western
blot
data
shown
specif
sera
examin
immunocytochem
assay
slide
contain
mix
mock
sarscovinfect
cell
sera
show
strong
reactiv
infect
cell
compar
pattern
cellular
stain
figur
immunocytochem
assay
obtain
antin
rabbit
sera
dilut
shown
particular
antin
rabbit
sera
could
still
detect
viral
antigen
dilut
data
shown
antisarscov
murin
sera
gener
show
lower
titr
irrespect
antigen
use
anim
sera
show
crossreact
human
coronaviru
data
shown
low
number
avail
sarsposit
sera
would
preclud
sound
assess
sensit
diagnost
effici
describ
inhous
elisa
test
studi
clearli
warrant
extend
investig
would
like
emphas
effect
recombin
antigenbas
elisa
test
particular
use
novel
antigen
detect
sarscovantibodi
addit
recombin
protein
found
use
gener
hyperimmun
sera
use
detect
viral
antigen
clinic
specimen
overal
result
strongli
suggest
effect
recombin
antigen
n
laboratori
diagnosi
sar
invit
extens
investig
valid
method
